Searched for
PANTOPRAZOLE
Alkem Labs to grow chronic therapies to drive future growth: MDThe Mumbai-based drug maker, which entered the US generics market over a decade ago, is also scaling back its investments in oral solids in...
IOL Chemicals gets EDQM certification for API supply to EuropeThe European Directorate for the Quality of Medicines & HealthCare (EDQM) is a mandatory certification for distribution of any API/ pharma ...
Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
Jubilant Cadista Inc recalls 63,216 bottles of erosive esophagitis tabletsThe reason for the recall is "CGMP Deviation: Presence of dark brown discoloration on edges of tablets," USFDA said. The ongoing voluntary ...
Popular antacid samples fail quality tests, company claims they were counterfeitsThe Pantocid and Pantocid DSR tested by CDSCO were not manufactured by Sun Pharma, the official spokesperson for the Mumbai-based drug make...
Dr Reddy's, Aurobindo recall drugs from US marketAccording to FDA, "Class-III" classification which was described as "a situation in which use of or exposure to a violative product is not ...
Aurobindo Pharma, Cadila recall drugs from US marketPantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux.
Aurobindo Pharma gets final USFDA nod for gastro reflux drugAurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the trea...
Pfizer reaches $2 billion Protonix settlement with Teva and Sun PharmaJapan's Takeda Pharmaceutical Co Ltd, Pfizer's partner, will receive 36 per cent or about $774 million from the settlement.
Jubilant arm recalls Pantoprazole Sodium drug from US marketThe US FDA cites the reason of recall as "cGMP deviations, oral products were not manufactured in accordance with good manufacturing practi...
- Jubilant receives USFDA approval for Pantoprazole tablets
Jubilant Life Sciences said it has received the US health regulator's approval for the launch of Pantoprazole Delayed Release Tablets.
- Takeda's $13bn Nycomed acquisition to benefit Zydus Cadila due to joint venture with Nycomed
The acquisition may have an impact over the next few months, and not a direct one, as Nycomed has a JV co with Zydus Cadila.
- Wockhardt gets USFDA approval to market generic Protonix
The company will manufacture the generic tablets at its US Food and Drug Administration's certified plant at Waluj, Maharashtra.
- Sun Pharma suffers second setback in US patent row
Sun Pharmaceutical Industries suffered its second setback in the US litigation within four days after a New Jersey district court decided t...
- Buy call on Sun Pharma by Religare & Motilal
Religare Research has maintained ‘buy’ on Sun Pharmaceutical Industries for a revised target of Rs 1,664 (Rs 1,347 previously), based on 18...
- Sun Pharma launches generic Protonix tablets
Sun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is A...
- Sun Pharma gets US nod for pantropazole
The approval for pantoprazole tablets, generic version of Wyeth's Protonix, is for multiple strengths of 20 mg and 40 mg.